Reports & Insights freshly released a new report entitled as “Digital Therapeutics Market: Opportunity Analysis and Future Assessment 2022-2030”, in which the base year is considered for the study is 2021, estimated year is 2022, and the forecasted year is considered 2023-2030. The global Digital Therapeutics Market in 2022 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ $ 22.9 Bn by 2030 with a significant CAGR of 25.8%. The report promises to offer its clients with an absolute across-the-board, premium quality primary data about the market prospects and in-depth knowledge of the trends prevailing in the market. The report further aims to provide a quantitative and qualitative synopsis of the theoretical framework and rational approach of the market expatiate using certified research methodologies and proficient expertise.
The global digital therapeutics market in 2020 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ 22.9 Bn by 2028 with a significant CAGR of 25.8%.
Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1123
Digital Therapeutics Introduction
The digital Therapeutics market includes a couple of segments such as application and end-use. The application segment further divided into six other categories such as diabetes, obesity, CVD, CNS, respiratory, and others. The end-user segment is further divided into patients, caregivers, employers, payers, and pharmaceutical companies.
Furthermore, the study includes market estimation, market forecast, and market information for six geographical regions around the globe. In 2016, in the U.S. diabetes is the seventh major cause of death, which affects around 10% of the U.S. population that is around 30.0 million and around 95% of diabetic patients have type 2 diabetes that is significantly associated with behavioral factors such as heavy calorie intake and less physical activity.
Digital Therapeutics Market Dynamics
In the healthcare system diabetes costs around US$ 245 Bn annually of which around US$ 176 Bn is included under direct medical costs. Medical management under digital therapeutics for the patients includes a change in diet recommendations, physical activities and smoking cessation, oral anti-diabetic agents, insulin therapy, and complication preventions that are linked with diabetes, such as cardiovascular risk factor management.
Change in demographics is one of the important aspects for the growth in the health care industry as most of the countries are experiencing a high percentage of transformation in the young population into the aged population. According to World Bank Data, in 2013, the total healthcare spending globally was $7.2 trillion, which accounts for around 11.0% of global GDP and expected to grow at more than 5.0% annually to 2018. The result of global healthcare spending leads to an increase in life expectancy that leads to an aging population.
Furthermore, the UN forecasts that the global share of the population over the age of 60 is expected to increase from 11.7% in 2013 to 21.1% in 2050, with rise in chronic ailments, which in turn is expected to favor the market for digital therapeutics market in the near future.
Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/report/global-digital-therapeutics-market
Digital Therapeutics Market Segmentation
The digital therapeutics market is segmented on the basis of application, product, sales channel, and region.
By Application
- Preventive Applications
- Prediabetes
- Obesity
- Nutrition
- Lifestyle Management
- Other Preventive Applications
- Treatment/Care-related Applications
- Diabetes
- CNS Disorders
- Mental Health Disorder
- Other CNS Disorders
- Chronic Respiratory Disorders
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Smoking Cessation
- Medication Adherence
- Gastrointestinal Disorders
- Substance Use & Addiction Management
- Rehabilitation & Patient Care
- Other Treatment/Care-related Applications
By Product
- Device
- Software
- Services
By Sales Channel
- Patient
- Caregiver
- Providers
- Payer
- Employer
- Pharma
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Digital Therapeutics Market Key Players
The global digital therapeutics market is mainly dominated by Omada Health, NeuroTrack Technologies, Inc., ZappRx, MEDIMETRICS, Arthro Therapeutics, BiogeniQ, Oviva AG, Healark, Pathology Diagnostics Ltd., between MD, LLC.
Digital Therapeutics Market Regional Overview and Analysis
On the basis of region, the global digital therapeutics market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America digital therapeutics market is expected to be the most dominating market throughout the forecast period due to an increasing number of biotechnology companies and research institutes in the U.S. Whereas, Europe will maintain its second-largest position with Germany and U.K being the most attractive markets within the region.
To view Top Players, Segmentation and other Statistics of Digital Therapeutics Industry, Get Sample Report: @ https://reportsandinsights.com/sample-request/1123
About Reports and Insights:
Reports and Insights is one of the leading market research company which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Neil Jonathan
1820 Avenue M, Brooklyn
NY 11230, United States
+1-(718) 312-8686
Find Us on LinkedIn: www.linkedin.com/company/report-and-insights/
View Latest Market Updates at: https://marketsresearchanalytics.com